MSG Publications

 

  1. Jackson CE, Gronseth G, Rosenfeld J, Barohn RJ, Dubinsky R, Simpson CB, McVey A, Kittrell PP, King R, Herbelin L, Muscle Study Group. Randomized double-blind study of botulinum toxin type B for sialorrhea in ALS patients. Muscle Nerve. 2009;39(2):137-43. PMID: 19145653.
  2. Burns TM, Conaway MR, Cutter GR, Sanders DB, Muscle Study Group. Less is more, or almost as much: a 15-item quality-of-life instrument for myasthenia gravis. Muscle Nerve. 2008;38(2):957-63. PMID: 18642357.
  3. Burns TM, Conaway MR, Cutter GR, Sanders DB, Muscle Study Group. Construction of an efficient evaluative instrument for myasthenia gravis: the MG composite. Muscle Nerve. 2008;38(6):1553-62. PMID: 19016543.
  4. Jackson CE, Barohn RJ, Gronseth G, Pandya S, Herbelin L, Muscle Study Group. Inclusion body myositis functional rating scale: a reliable and valid measure of disease severity. Muscle Nerve. 2008;37(4):473-6. PMID: 18236463.
  5. Mullins LL, Carpentier MY, Paul RH, Sanders DB, Muscle Study Group. Disease-specific measure of quality of life for myasthenia gravis. Muscle Nerve. 2008;38(2):947-56. PMID: 18697209.
  6. Muscle Study Group. A trial of mycophenolate mofetil with prednisone as initial immunotherapy in myasthenia gravis. Neurology. 2008;71(6):394-9. PMID: 18434639.
  7. Vernino S, Lindstrom J, Hopkins S, Wang Z, Low PA, Muscle Study Group. Characterization of ganglionic acetylcholine receptor autoantibodies. J Neuroimmunol. 2008;197(1):63-9. PMID: 18485491. PMC2536520.
  8. Wolfe GI, Barohn RJ, Sanders DB, McDermott MP, Muscle Study Group. Comparison of outcome measures from a trial of mycophenolate mofetil in myasthenia gravis. Muscle Nerve. 2008;38(5):1429-33. PMID: 18949779.
  9. O'Hagen JM, Glanzman AM, McDermott MP, Ryan PA, Flickinger J, Quigley J, Riley S, Sanborn E, Irvine C, Martens WB, Annis C, Tawil R, Oskoui M, Darras BT, Finkel RS, De Vivo DC. An expanded version of the Hammersmith Functional Motor Scale for SMA II and III patients. Neuromuscul Disord. 2007;17(9-10):693-7. PMID: 17658255.
  10. Bushby K, Griggs R. 145th ENMC International Workshop: planning for an International Trial of Steroid Dosage Regimes in DMD (FOR DMD), 22-24th October 2006, Naarden, The Netherlands. Neuromuscul Disord. 2007;17(5):423-8. PMID: 17433676.
  11. Muscle Study Group. Randomized pilot trial of high-dose betaINF-1a in patients with inclusion body myositis. Neurology. 2004;63(4):718-20. PMID: 15326251.
  12. Muscle Study Group. Randomized pilot trial of betaINF1a (Avonex) in patients with inclusion body myositis. Neurology. 2001;57(9):1566-70. PMID: 11706093.


Abstracts

  1. Burns TM, Conaway M, Sanders DB, Muscle Study Group. Correlation of quality-of-life with regional symptoms and signs in MG: Muscle Study Group CellCept trial experience. Ann NY Acad Sci 2008; 1132:369-370. (Abstract)
  2. Massey JM, Sanders DB, Saperstein DS, Barohn RJ, Meriggioli MN, Nations SP, Muscle Study Group. Comparison of single fiber EMG studies to outcome measures in a controlled study of mycophenolate mofetil in generalized MG. Ann NY Acad Sci 2008; 1132:377. (Abstract)